Pass the Stem Cell Therapeutic and Research Reauthorization Act of 2025.

Ken Calvert · California · Republican

policy impact 3.00 specificity 1.00 extraction confidence 92%

Contest this claim

Occurrences

Evidence

The House Energy and Commerce Health Subcommittee reported H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025, to the full committee by voice vote.

This is a concrete committee-stage advance for the reauthorization bill, but not final passage.

partial same_term A for effort

Health Subcommittee Advances Public Health Reauthorizations and Policies to Improve FDA and Medicare to Full Committee
primary · model gpt-5.4-mini · confidence 96%

Contest this evidence item

The House Energy and Commerce Committee reported H.R. 5160 to the full House as amended by a roll call vote of 46 yeas to 0 nays.

This is the strongest official sign of progress so far, but the bill still was not enacted or even shown as passed by both chambers.

partial same_term A for effort

E&C Advances 16 Bills to Full House
primary · model gpt-5.4-mini · confidence 99%

Contest this evidence item

Assessments

never unknown A for effort

The bill advanced through House committee stages in May 2026, including subcommittee and full committee action, but there is no evidence that it passed the House and Senate or was enacted. That means Calvert showed legislative effort, but the promised outcome of passing the Stem Cell Therapeutic and Research Reauthorization Act of 2025 was not delivered.

provider codex_cli · model gpt-5.4-mini · confidence 96%